-
-
In a series of patients with MDS, the presence of peripheral blood eosinophilia, basophilia, eosinopenia, and basopenia were each shown to offer prognostic information with regard to overall survival. This information was shown to be of particular additional value for patients with IPSS-Int-2 risk subgroup.
-
Imatinib at 400 mg daily leads to high response rates for chronic-phase CML, but a subset has suboptimal response and/or toxicity. In this study, 846 subjects were randomized to receive nilotinib, a more selective bcr/abl tyrosine kinase inhibitor, at 300 mg BID or 400 mg BID vs. imatinib at 400 mg daily.
-
New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions
-
-
Once the details are ironed out, health care reform will offer great opportunities for case managers in a variety of settings, says Margaret Leonard, MS, RN-B, C, FNP, senior vice president for clinical services at Hudson Health Plan and outgoing president of the Case Management Society of America (CMSA).
-
Consider evaluating educational materials, such as an educational sheet, self-care instructions, or an informational website, with a usability test instead of a focus group, says Dana Botka, manager of customer communications with the Washington Department of Labor and Industries in Olympia.
-
When Nick Masi, PhD, director of Family Centered Care at Joe DiMÿ
-
-
At DuBois (PA) Regional Medical Center, employees were failing N95 fit tests in alarming numbers. In the cardiology department, about 46% of employees failed fit-tests even after trying a variety of models and sizes. Things weren't much better in anesthesia (35%), cardiovascular ICU (34%), or the emergency department (26%).